Close Menu

NEW YORK (360Dx) – During April, the US Food and Drug Administration cleared in vitro diagnostic tests from Roche Diagnostics, Beckman Coulter, Cepheid, Genmark Diagnostics and others, according to the agency's website.

Roche Diagnostics received clearance for its Elecsys TSH electrochemiluminescence immunoassay, which is used for the diagnosis of thyroid and pituitary disorders while running on the firm's Cobas e immunoassay analyzer.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.